Effectiveness and safety of stellate ganglion block with trioxygen autologous blood retransfusion therapy for facial postherpetic neuralgia in elderly patients.

ABSTRACT: This study evaluated the efficacy and safety of stellate ganglion block (SGB) combined with trioxygen autologous blood retransfusion therapy (TABRT) in treating postherpetic neuralgia (PHN) of the head and face in elderly patients. A total of 190 patients (aged ≥ 60 years) with PHN were randomly assigned to receive either drug treatment alone (Group D, n = 40), drug treatment with SGB (Group DS, n = 52), drug treatment with TABRT (Group DT, n = 53), or drug combined SGB with TABRT (Group DST, n = 45). Key outcomes included pain visual analogue scale (VAS) scores and anxiety levels at baseline, 7 days, and 15 days post-treatment, the need for salvage analgesics, and complication rates assessed. All groups showed significant improvements in pain and anxiety, with greater reductions in the DS

SUBMITTER: Zheng C 

PROVIDER: S-EPMC11889258 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature